Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SciFluor Life Sciences LLC

www.scifluor.com

Latest From Amira Medical

Two Rising Stars in Glucose Testing

Despite its attraction, diabetes glucose monitoring remains a tough field for newcomers, who face competition from four major-league, entrenched players. But two of the newer entrants appear to be succeeding--not because of revolutionary technology, but because of partnering savvy, efficient execution, and technological competence. Analysts expect Inverness Medical's symbiotic relationship with LifeScan to help Inverness's diabetes sales grow 30% a year as LifeScan pushes Inverness-made products as a major part of its fight to regain its market leadership. Home Diagnostics Inc.'s success with co-branding raises the prospect that discounting, until now not a significant factor, will become much more common in the field.
Medical Device Strategy

A Robust IPO Market--even for Devices?

Anyone who stood in the packed room at this year's Chase Hambrecht & Quist meeting in San Francisco in early January for the presentation by e-commerce player Neoforma.com Inc. could hardly be surprised by the results of the company's IPO, which went out the week following, raising $91 million for the B2B supply chain manager. But as well as the Neoforma public offering did, it was, arguably, nothing compared to the IPO of Aspect Medical Systems Inc., a manufacturer of depth-of-anesthesia monitoring devices.
Medical Device Leadership

Just Around the Corner: Pursuing the Elusive Diabetes Market

Diabetes seems like a great clinical and commercial opportunity but it's been a technological nightmare for many small device and diagnostic companies. Still, there's enough good news coming out of R&D to keep entrepreneurs going
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
  • Therapeutic Areas
  • Inflammation
  • Neurology, Nervous System
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • SciFluor Life Sciences LLC
  • Senior Management
  • Omar Amirana, MD, CEO
    Ben C Askew, PhD, VP, Research
  • Contact Info
  • SciFluor Life Sciences LLC
    Phone: (617) 419-1822
    33 Arch St.
    Ste. 3201
    Boston, MA 02110
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register